299 related articles for article (PubMed ID: 18209071)
21. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
Hudrisier D; Oldstone MB; Gairin JE
Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
[TBL] [Abstract][Full Text] [Related]
22. T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein.
Abel LC; Iwai LK; Viviani W; Bilate AM; Faé KC; Ferreira RC; Goldberg AC; Juliano L; Juliano MA; Ianni B; Mady C; Gruber A; Hammer J; Sinigaglia F; Kalil J; Cunha-Neto E
Microbes Infect; 2005; 7(11-12):1184-95. PubMed ID: 15951215
[TBL] [Abstract][Full Text] [Related]
23. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses.
Wizel B; Palmieri M; Mendoza C; Arana B; Sidney J; Sette A; Tarleton R
J Clin Invest; 1998 Sep; 102(5):1062-71. PubMed ID: 9727076
[TBL] [Abstract][Full Text] [Related]
24. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection.
Miyahira Y; Takashima Y; Kobayashi S; Matsumoto Y; Takeuchi T; Ohyanagi-Hara M; Yoshida A; Ohwada A; Akiba H; Yagita H; Okumura K; Ogawa H
Infect Immun; 2005 Nov; 73(11):7356-65. PubMed ID: 16239534
[TBL] [Abstract][Full Text] [Related]
25. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.
Wizel B; Garg N; Tarleton RL
Infect Immun; 1998 Nov; 66(11):5073-81. PubMed ID: 9784506
[TBL] [Abstract][Full Text] [Related]
26. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes.
Wrightsman RA; Dawson BD; Fouts DL; Manning JE
J Immunol; 1994 Oct; 153(7):3148-54. PubMed ID: 7522250
[TBL] [Abstract][Full Text] [Related]
27. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
Padilla A; Xu D; Martin D; Tarleton R
Infect Immun; 2007 Jan; 75(1):231-5. PubMed ID: 17043105
[TBL] [Abstract][Full Text] [Related]
28. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes.
Marañón C; Thomas MC; Planelles L; López MC
Mol Immunol; 2001 Aug; 38(4):279-87. PubMed ID: 11566321
[TBL] [Abstract][Full Text] [Related]
29. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients.
Fonseca SG; Moins-Teisserenc H; Clave E; Ianni B; Nunes VL; Mady C; Iwai LK; Sette A; Sidney J; Marin ML; Goldberg AC; Guilherme L; Charron D; Toubert A; Kalil J; Cunha-Neto E
Microbes Infect; 2005 Apr; 7(4):688-97. PubMed ID: 15848276
[TBL] [Abstract][Full Text] [Related]
30. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
[TBL] [Abstract][Full Text] [Related]
31. Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with recombinant adenoviruses encoding amastigote surface protein-2 and trans-sialidase.
Machado AV; Cardoso JE; Claser C; Rodrigues MM; Gazzinelli RT; Bruna-Romero O
Hum Gene Ther; 2006 Sep; 17(9):898-908. PubMed ID: 16972758
[TBL] [Abstract][Full Text] [Related]
32. A Trypanosoma cruzi small surface molecule provides the first immunological evidence that Chagas' disease is due to a single parasite lineage.
Di Noia JM; Buscaglia CA; De Marchi CR; Almeida IC; Frasch AC
J Exp Med; 2002 Feb; 195(4):401-13. PubMed ID: 11854354
[TBL] [Abstract][Full Text] [Related]
33. Immunodominance of Adenovirus-Derived CD8
Schöne D; Hrycak CP; Windmann S; Lapuente D; Dittmer U; Tenbusch M; Bayer W
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768877
[TBL] [Abstract][Full Text] [Related]
34. A human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.
Pereira IR; Vilar-Pereira G; Marques V; da Silva AA; Caetano B; Moreira OC; Machado AV; Bruna-Romero O; Rodrigues MM; Gazzinelli RT; Lannes-Vieira J
PLoS Pathog; 2015 Jan; 11(1):e1004594. PubMed ID: 25617628
[TBL] [Abstract][Full Text] [Related]
35. Avidity of CD8 T cells sharpens immunodominance.
Dzutsev AH; Belyakov IM; Isakov DV; Margulies DH; Berzofsky JA
Int Immunol; 2007 Apr; 19(4):497-507. PubMed ID: 17376783
[TBL] [Abstract][Full Text] [Related]
36. Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigen.
Rampazo EV; Amorim KN; Yamamoto MM; Panatieri RH; Rodrigues MM; Boscardin SB
PLoS One; 2015; 10(2):e0117778. PubMed ID: 25679777
[TBL] [Abstract][Full Text] [Related]
37. Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.
Gironès N; Rodríguez CI; Carrasco-Marín E; Hernáez RF; de Rego JL; Fresno M
J Clin Invest; 2001 Apr; 107(8):985-93. PubMed ID: 11306602
[TBL] [Abstract][Full Text] [Related]
38. Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.
Lee S; Miller SA; Wright DW; Rock MT; Crowe JE
J Virol; 2007 Mar; 81(5):2349-58. PubMed ID: 17182672
[TBL] [Abstract][Full Text] [Related]
39. Induction of CD8+ T cell-mediated protective immunity against Trypanosoma cruzi.
Miyahira Y; Kobayashi S; Takeuchi T; Kamiyama T; Nara T; Nakajima-Shimada J; Aoki T
Int Immunol; 1999 Feb; 11(2):133-41. PubMed ID: 10069411
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
